Seminars in Nuclear Medicine
Volume 40, Issue 5 , Pages 338-346, September 2010

The Role of the Core Imaging Laboratory in Multicenter Trials

Molecular Neuroimaging, LLC, Institute for Neurodegenerative Disorders, and Yale University School of Medicine, New Haven, CT

The incorporation of imaging biomarkers and clinical trials is now common. Because of the multiple technical, clinical, and regulatory demands to ensure high-quality quantitative information, the core laboratory serves as a critical intermediary between the study sponsor and the site. It provides unique expertise not found in typical clinical research organizations. This expertise goes far beyond the passive receipt of images for conductance of central reads of data and includes the proactive and early involvement in the selection of sites for imaging, the qualification and assistance for managing the local site logistics, on-the-fly and active quality control of imaging data in close working relationship with sites, and preparation for and conductance of central image reads or quantification in a manner which bears up to regulatory scrutiny.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(10)00017-6

doi:10.1053/j.semnuclmed.2010.03.002

Seminars in Nuclear Medicine
Volume 40, Issue 5 , Pages 338-346, September 2010